ENTITY
Shandong Weigao Group Medical Polymer

Shandong Weigao Group Medical Polymer (1066 HK)

82
Analysis
Health Care • China
Shandong Weigao Group Medical Polymer Co. Ltd. is primarily engaged in the research and development, production, and sale of medical devices, focusing on single-use medical device products. Their extensive product portfolio includes consumables such as infusion sets, syringes, and blood bags, alongside orthopedic, interventional, pharma packaging, and blood management products. The company was founded in 1988 and is headquartered in Weihai, China.
more
bullish•ZhongAn Online
•21 May 2020 16:47

CPPCC And Full Circulation Of H-Shares

After being delayed two months, the 2020 National People's Congress and Chinese People's Political Consultative began its annual session today,...

Logo
550 Views
Share
•24 Feb 2020 21:13

Full Circulation Of H Shares: Signs Of Life

On the 29 December 2017, the China Securities Regulatory Commission's ("CSRC") announced it would launch the H-share Full Circulation Pilot...

Logo
636 Views
Share
bearish•Quantitative Analysis
•22 Nov 2019 17:45

HK - Sniffing Out The Shorts

We analyse the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 15 November.Total short notional...

Logo
661 Views
Share
bullish•China Tower
•19 Nov 2019 18:28

CSRC Green Lights Full Circulation Of H Shares

Back in June last year, I flagged (Legend's Conversion of Domestic Shares) 850mn shares entering Legend Holdings Corp H (3396 HK)'s share registry...

Logo
966 Views
Share
bearish•Sinopharm Group
•21 Aug 2018 00:31

China Medical Devices: "Two-Invoice" Is Coming

Sinopharm Group Co H (1099 HK) 's pending acquisition of a majority interest in China National Scientific Instruments and Materials Co. Ltd....

Share
x